Mehdi Hamadani, MD (@medihumdani) 's Twitter Profile
Mehdi Hamadani, MD

@medihumdani

BMT & Cellular Therapy | Secretary @ASTCT | Co-Chair @ASTCT CoPG | #bmtsm #CARTcell #lymsm | Personal views | Doctor not Provider | 🇵🇰 🏏 🇺🇸 🏈

ID: 1424156964

calendar_today12-05-2013 22:40:18

7,7K Tweet

11,11K Takipçi

3,3K Takip Edilen

Mark Cuban (@mcuban) 's Twitter Profile Photo

This is exactly why PBMs should not be allowed to offer Formularies. Excluding zepbound is as pay for play as it gets, and has nothing to do with clinical value to patients. It takes the control of patient wellness out of the hands of doctors and patients and into the hands of

International Myeloma Foundation (@imfmyeloma) 's Twitter Profile Photo

Congratulations to Saad Z. Usmani MD MBA FACP 🇺🇸🇵🇰 on being recognized by The OncLive.com Giants of Cancer Care program. Currently Chief of Myeloma Service at Memorial Sloan Kettering Cancer Center , Dr. Usmani is also a member of The International Myeloma Foundation's Scientific Advisory Board. onclive.com/view/giants-of…

Mehdi Hamadani, MD (@medihumdani) 's Twitter Profile Photo

If done correctly, it will be a highly impactful executive order to reduce astronomically ridiculous drug costs in the U.S.A. #CART #genetherapy #cancermed #targetedagents all unfairly prices in USA

Mehdi Hamadani, MD (@medihumdani) 's Twitter Profile Photo

Furthering our work for best strategy in established chemosensitive MYC+ LBCL #lymsm CART of autoHCT? #bmtsm Fateeha Furqan et al. onlinelibrary.wiley.com/doi/full/10.10…